高级检索
    江志敏, 谢德荣, 赖晓嵘. 白蛋白紫杉醇联合吉西他滨与FOLFIRINOX治疗晚期胰腺癌真实世界研究的疗效评价[J]. 循证医学, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
    引用本文: 江志敏, 谢德荣, 赖晓嵘. 白蛋白紫杉醇联合吉西他滨与FOLFIRINOX治疗晚期胰腺癌真实世界研究的疗效评价[J]. 循证医学, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
    shu
    JIANG Zhi-min, XIE De-rong, LAI Xiao-rong. Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
    Citation: JIANG Zhi-min, XIE De-rong, LAI Xiao-rong. Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 264-266. DOI: 10.12019/j.issn.1671-5144.2019.05.003
    shu

    白蛋白紫杉醇联合吉西他滨与FOLFIRINOX治疗晚期胰腺癌真实世界研究的疗效评价

    Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer

      摘要
      • HTML全文
      • 参考文献(6)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回